Advertisement

Related Videos

David T. Rubin, MD, on Biosimilars for Inflammatory Bowel Disease

Mark J. Ratain, MD: The Justification for a Randomized Trial of Low-Dose Ibrutinib

Javid J. Moslehi, MD, on Cardiovascular and Thrombotic Considerations of Kinase Inhibitors: The Case of BTK Inhibitors

Opportunities to Optimize Cancer Policies Panel Discussion

CS Pramesh, MS, FRCS, on Opportunities in India: A Perspective From a Low-Middle Income Country

Advertisement

Advertisement




Apr
26
Today In Oncology
Use of Statins in CLL/SLL
High-Fiber Diet May Slow Disease Progression to Multiple Myeloma
Omission of Endocrine Therapy in Estrogen Receptor-Low Early-Stage Breast Cancer
Childhood Exposure to Bacterial Toxin May Trigger Early Onset Colorectal Cancer
WHI Funding Future Unclear
View More 
Advertisement
© 2025 HSP News Service, L.L.C.
Conexiant Oncology Logo